Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine Hippurate for UTI Prevention
NCT03996057Phase 4Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2018
- Primary completion
- Feb 2022
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 4 trial of methenamine hippurate in urinary tract infection (UTI), sponsored by Washington University School of Medicine. Planned start Jun 2018; status: withdrawn.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03996057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996057.